Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société INOVIO PHARMACEUTICALS, INC.
10/12INOVIO PHARMACEUTICALS : Announces Online Preprint Publication of Homologous Boosting Data..
PR
10/11INOVIO PHARMACEUTICALS : Expands INNOVATE Phase 3 for INO-4800, its DNA Vaccine Candidate ..
PR
09/29INOVIO PHARMACEUTICALS : to Present Three Posters at IDWeek 2021
PR
09/22INOVIO PHARMACEUTICALS : Receives Regulatory Authorization to Conduct Phase 3 Efficacy Tri..
PR
09/01INOVIO PHARMACEUTICALS : to Present at Upcoming Investor Conferences in September
PR
08/26INOVIO PHARMACEUTICALS : Receives Authorization to Conduct Phase 3 Efficacy Trial of its C..
PR
08/09INOVIO : Q2 Earnings Snapshot
AQ
08/09INOVIO PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results
PR
08/09INOVIO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
08/09INOVIO PHARMACEUTICALS : and Advaccine Receive Regulatory Allowance for Two Heterologous P..
PR
08/04INOVIO PHARMACEUTICALS : Doses First Participant in Phase 2 Trial for its DNA Vaccine Agai..
PR
07/26INOVIO PHARMACEUTICALS : to Report Second Quarter 2021 Financial Results on August 9, 2021
PR
06/11INOVIO PHARMACEUTICALS : Expands Partnership with Advaccine to Conduct Global Phase 3 Effi..
PU
06/11INOVIO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Regulation FD D..
AQ
06/08INOVIO PHARMACEUTICALS : Expands Partnership with Advaccine to Conduct Global Phase 3 Effi..
PR
05/25INOVIO PHARMACEUTICALS : to Present at the Jefferies 2021 Virtual Healthcare Conference
PR
05/17INOVIO PHARMACEUTICALS : Appointment of industry leader in drug development expands the Bo..
PU
05/17INOVIO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of Ma..
AQ
05/17INOVIO PHARMACEUTICALS : Announces Appointment Of Roger Dansey, M.D., to its Board of Dire..
PR
05/12INOVIO PHARMACEUTICALS : Pan-COVID-19 Vaccine Candidate (INO-4802) Induces Broad Immunity ..
PR
05/10INOVIO : Q1 Earnings Snapshot
AQ
05/10INOVIO PHARMACEUTICALS : Reports First Quarter 2021 Financial Results
PR
05/10INOVIO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
05/10INOVIO PHARMACEUTICALS : confirms its Covid vaccine is safe in mid-stage trials
AQ
05/10INOVIO PHARMACEUTICALS : Announces Positive Data from Phase 2 Segment of Clinical Trial Ev..
PR
05/04INOVIO PHARMACEUTICALS : to Present at Upcoming Investor Conferences in May
PR
04/27INOVIO PHARMACEUTICALS : to Report First Quarter 2021 Financial Results on May 10, 2021
PR
04/23INOVIO PHARMACEUTICALS : Planning for ex-US Global Phase 3 Trial for INO-4800
PR
04/15INOVIO PHARMACEUTICALS : COVID-19 Vaccine Candidate, INO-4800, Provides Broad Cross-reacti..
PR
04/09INOVIO INVESTIGATION CONTINUED BY FO : Kahn Swick & Foti, LLC Continues to Investigate the..
BU
03/04INOVIO PHARMACEUTICALS : to Present at Upcoming Investor Conferences in March
PR
03/03INOVIO PHARMACEUTICALS : Geneos Therapeutics Secures $12 Million in Series A1 Financing to..
PR
03/01INOVIO : 4Q Earnings Snapshot
AQ
03/01INOVIO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulation F..
AQ
03/01INOVIO PHARMACEUTICALS : Reports Fourth Quarter 2020 and Year-End Financial Results
PR
03/01INOVIO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
03/01INOVIO PHARMACEUTICALS : Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial..
PR
03/01VELOCITY FINANCIAL : Initial Decisions On Motions To Dismiss COVID-19 Securities Class Act..
AQ
02/26INOVIO INVESTIGATION INITIATED BY FO : Kahn Swick & Foti, LLC Investigates the Officers an..
BU
02/23INOVIO PHARMACEUTICALS : Announces First Subject Dosed in Phase 1B Clinical Trial for its ..
PR
02/16INOVIO PHARMACEUTICALS : to Report Fourth Quarter and Full Year 2020 Financial Results on ..
PR
01/25INOVIO PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock and Full Exe..
PR
01/22INOVIO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, F..
AQ
01/20INOVIO PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
PR
01/20INOVIO PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
PR
01/20INOVIO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Other Events..
AQ
01/06INOVIO PHARMACEUTICALS : VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of P..
PR
01/04INOVIO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Regulation FD D..
AQ
01/04INOVIO PHARMACEUTICALS : and Advaccine Announce Exclusive Partnership To Commercialize COV..
PR
2020INOVIO PHARMACEUTICALS : Announces Publication of Phase 1 Data from its COVID-19 DNA Vacci..
PR
2020INOVIO PHARMACEUTICALS : to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to ..
PR
2020INOVIO PHARMACEUTICALS : and Advaccine Announce First Dosing of Subject in Phase 2 Clinica..
PR
2020INOVIO PHARMACEUTICALS : Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 ..
PR
2020INOVIO PHARMACEUTICALS : Expands Global Manufacturing Consortium For Its COVID-19 Vaccine ..
PR
2020INOVIO PHARMACEUTICALS : Announces Dosing of First Subject in Phase 1/2 Clinical Trial for..
PR
2020INOVIO PHARMACEUTICALS : Presents Clinical Results of its DNA Medicines INO-5401 + INO-901..
PR
2020INOVIO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020INOVIO PHARMACEUTICALS : Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical..
PR
2020INOVIO : 3Q Earnings Snapshot
AQ
2020INOVIO PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results
PR
2020INOVIO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
2020INOVIO PHARMACEUTICALS : to Report Third Quarter 2020 Financial Results on November 9, 202..
PR
2020INOVIO PHARMACEUTICALS, INC. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2020INOVIO PHARMACEUTICALS : Thinking about buying stock in Sorrento Therapeutics, New Age Bev..
PR
2020Diageo, Cleveland-Cliffs rise; Aquestive, Inovio fall
AQ
2020Diageo, Cleveland-Cliffs rise; Aquestive, Inovio fall
AQ
2020INOVIO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020INOVIO PHARMACEUTICALS : Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial o..
PR
2020INOVIO PHARMACEUTICALS : Adds Thermo Fisher Scientific To Global Manufacturing Consortium
PR
2020INOVIO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020INOVIO PHARMACEUTICALS : to Present at Upcoming Investor Conferences in September
PR
2020SB Capital Management Inc. continues its expansion with the inclusion of 4 investment f..
AQ
2020Nautilus, HD Supply rise; Uber, Inovio fall
AQ
2020INOVIO : 2Q Earnings Snapshot
AQ
2020INOVIO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
1  2  3  4  5  6Next
Upcoming event on INOVIO PHARMACEUTICALS, INC.
11/10/21